drugset / Trial / NCT02959996

Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain

NCT02959996

Phase 2/3 Completed 80 enrolled Massachusetts General Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized controlled trial to test whether the use of liposomal bupivacaine at the time of cesarean delivery may decrease post-operative pain scores.

Timeline

Start
2017-03-08
Primary completion
2017-09-25
Completion
2017-11-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified

Indications